{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:12:03Z","timestamp":1793884323952,"version":"4.7.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R24AG045050-03S2"],"award-info":[{"award-number":["R24AG045050-03S2"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1K24AG056578-01"],"award-info":[{"award-number":["1K24AG056578-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["K23AG054742"],"award-info":[{"award-number":["K23AG054742"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s40266-018-00630-z","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T01:53:56Z","timestamp":1547690036000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4127-4617","authenticated-orcid":false,"given":"Ariel R.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza M.","family":"Reifler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Weffald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"issue":"11","key":"630_CR1","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"American Geriatrics Society","year":"2015","unstructured":"American Geriatrics Society. Updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227\u201346. \n                    https:\/\/doi.org\/10.1111\/jgs.13702\n                    \n                  .","journal-title":"J Am Geriatr Soc."},{"issue":"9","key":"630_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/014107680009300903","volume":"93","author":"J Mintzer","year":"2000","unstructured":"Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000;93(9):457\u201362.","journal-title":"J R Soc Med"},{"issue":"5","key":"630_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1532-5415.2011.03386.x","volume":"59","author":"NM Wilson","year":"2011","unstructured":"Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc. 2011;59(5):875\u201380.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"630_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/pds.3624","volume":"23","author":"PS Nishtala","year":"2014","unstructured":"Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"630_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JCP.0000000000000195","volume":"34","author":"V Dauphinot","year":"2014","unstructured":"Dauphinot V, Faure R, Omrani S, Goutelle S, Bourguignon L, Krolak-Salmon P, et al. Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort. J Clin Psychopharmacol. 2014;34(5):565\u201370.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"630_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S1041610202008505","volume":"14","author":"D Aizenberg","year":"2002","unstructured":"Aizenberg D, Sigler M, Weizman A, Barak Y. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr. 2002;14(3):307\u201310.","journal-title":"Int Psychogeriatr"},{"issue":"11","key":"630_CR7","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1177\/1060028015596998","volume":"49","author":"ZA Marcum","year":"2015","unstructured":"Marcum ZA, Perera S, Thorpe JM, Switzer GE, Gray SL, Castle NG, et al. Anticholinergic use and recurrent falls in community-dwelling older adults: findings from the Health ABC study. Ann Pharmacother. 2015;49(11):1214\u201321.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"630_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/jgs.13543","volume":"63","author":"K Richardson","year":"2015","unstructured":"Richardson K, Bennett K, Maidment ID, Fox C, Smithard D, Kenny RA. Use of medications with anticholinergic activity and self-reported injurious falls in older community-dwelling adults. J Am Geriatr Soc. 2015;63(8):1561\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"630_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.maturitas.2015.10.009","volume":"84","author":"A Zia","year":"2016","unstructured":"Zia A, Kamaruzzaman S, Myint PK, Tan MP. Anticholinergic burden is associated with recurrent and injurious falls in older individuals. Maturitas. 2016;84:32\u20137.","journal-title":"Maturitas."},{"issue":"10","key":"630_CR10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40266-015-0310-9","volume":"32","author":"K Cardwell","year":"2015","unstructured":"Cardwell K, Hughes CM, Ryan C. The association between anticholinergic medication burden and health related outcomes in the \u2018oldest old\u2019: a systematic review of the literature. Drugs Aging. 2015;32(10):835\u201348.","journal-title":"Drugs Aging"},{"issue":"3","key":"630_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40266-014-0158-4","volume":"31","author":"MS Salahudeen","year":"2014","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review. Drugs Aging. 2014;31(3):185\u201392.","journal-title":"Drugs Aging"},{"issue":"3","key":"630_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401\u20137.","journal-title":"JAMA Intern Med."},{"key":"630_CR13","first-page":"225","volume":"4","author":"N Campbell","year":"2009","unstructured":"Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225\u201333.","journal-title":"Clin Interv Aging"},{"key":"630_CR14","unstructured":"Agency for Healthcare Research and Quality. Chronic condition classification. \n                    http:\/\/www.icpsr.umich.edu\/icpsrweb\/content\/AHRQMCC\/shared-code.html\n                    \n                  . Accessed 14 Aug 2017."},{"issue":"9","key":"630_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/jamainternmed.2016.3553","volume":"176","author":"H Amjad","year":"2016","unstructured":"Amjad H, Carmichael D, Austin AM, Chang CH, Bynum JP. Continuity of care and health care utilization in older adults with dementia in fee-for-service medicare. JAMA Intern Med. 2016;176(9):1371\u20138.","journal-title":"JAMA Intern Med."},{"issue":"S1","key":"630_CR16","first-page":"S142","volume":"61","author":"NL Campbell","year":"2013","unstructured":"Campbell NL, Maidment I, Fox C, Khan B, Boustani M. The 2012 update to the anticholinergic cognitive burden scale. J Am Geriatr Soc. 2013;61(S1):S142\u20133.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"630_CR17","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/phar.1843","volume":"36","author":"NL Campbell","year":"2016","unstructured":"Campbell NL, Perkins AJ, Bradt P, Perk S, Wielage RC, Boustani MA, et al. Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population. Pharmacotherapy. 2016;36(11):1123\u201331.","journal-title":"Pharmacotherapy."},{"issue":"7","key":"630_CR18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/MLR.0000000000000531","volume":"54","author":"GJ Hoffman","year":"2016","unstructured":"Hoffman GJ, Hays RD, Shapiro MF, Wallace SP, Ettner SL. Claims-based Identification methods and the cost of fall-related injuries among US older adults. Med Care. 2016;54(7):664\u201371.","journal-title":"Med Care"},{"issue":"1","key":"630_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jgs.13206","volume":"63","author":"MS Salahudeen","year":"2015","unstructured":"Salahudeen MS, Hilmer SN, Nishtala PS. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc. 2015;63(1):85\u201390.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"630_CR20","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1111\/jgs.14439","volume":"64","author":"M Nilsson","year":"2016","unstructured":"Nilsson M, Eriksson J, Larsson B, Oden A, Johansson H, Lorentzon M. fall risk assessment predicts fall-related injury, hip fracture, and head injury in older adults. J Am Geriatr Soc. 2016;64(11):2242\u201350.","journal-title":"J Am Geriatr Soc"},{"key":"630_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2016.11.005","volume":"35","author":"HA Beydoun","year":"2017","unstructured":"Beydoun HA, Beydoun MA, Mishra NK, Rostant OS, Zonderman AB, Eid SM. Comorbid Parkinson\u2019s disease, falls and fractures in the 2010 National Emergency Department Sample. Parkinsonism Relat Disord. 2017;35:30\u20135.","journal-title":"Parkinsonism Relat Disord."},{"key":"630_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2318-9-30","volume":"9","author":"S Berdot","year":"2009","unstructured":"Berdot S, Bertrand M, Dartigues JF, Fourrier A, Tavernier B, Ritchie K, et al. Inappropriate medication use and risk of falls\u2014a prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 2009;9:30.","journal-title":"BMC Geriatr."},{"issue":"1","key":"630_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2318-15-2","volume":"15","author":"CA Alvarez","year":"2015","unstructured":"Alvarez CA, Mortensen EM, Makris UE, Berlowitz DR, Copeland LA, Good CB, et al. Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort study. BMC Geriatr. 2015;15(1):2.","journal-title":"BMC Geriatr."},{"issue":"1","key":"630_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12877-016-0251-0","volume":"16","author":"ZA Marcum","year":"2016","unstructured":"Marcum ZA, Wirtz HS, Pettinger M, LaCroix AZ, Carnahan R, Cauley JA, et al. Anticholinergic medication use and falls in postmenopausal women: findings from the women\u2019s health initiative cohort study. BMC Geriatr. 2016;16(1):76.","journal-title":"BMC Geriatr."},{"issue":"7","key":"630_CR25","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/jgs.14182","volume":"64","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Bali V, Carnahan RM, Chen H, Johnson ML, Aparasu RR. Anticholinergic medication use and risk of fracture in elderly adults with depression. J Am Geriatr Soc. 2016;64(7):1492\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"630_CR26","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1177\/1060028014535363","volume":"48","author":"LA Fraser","year":"2014","unstructured":"Fraser LA. Effect of anticholinergic medications on falls, fracture risk, and bone mineral density over a 10-year period. Ann Pharmacother. 2014;48(8):954\u201361.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"630_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/jcph.1067","volume":"58","author":"LT Kao","year":"2018","unstructured":"Kao LT, Huang CY, Lin HC, Chu CM. No increased risk of fracture in patients receiving antimuscarinics for overactive bladder syndrome: a retrospective cohort study. J Clin Pharmacol. 2018;58(6):727\u201332.","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"630_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40266-015-0298-1","volume":"32","author":"ZA Marcum","year":"2015","unstructured":"Marcum ZA, Wirtz HS, Pettinger M, LaCroix AZ, Carnahan R, Cauley JA, et al. Anticholinergic medication use and fractures in postmenopausal women: findings from the women\u2019s health initiative. Drugs Aging. 2015;32(9):755\u201363.","journal-title":"Drugs Aging"},{"issue":"10","key":"630_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jamda.2013.03.008","volume":"14","author":"DC Moga","year":"2013","unstructured":"Moga DC, Carnahan RM, Lund BC, Pendergast JF, Wallace RB, Torner JC, et al. Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living Centers. J Am Med Dir Assoc. 2013;14(10):749\u201360.","journal-title":"J Am Med Dir Assoc."},{"issue":"5","key":"630_CR30","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1532-5415.2008.01680.x","volume":"56","author":"TE Lackner","year":"2008","unstructured":"Lackner TE, Wyman JF, McCarthy TC, Monigold M, Davey C. Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence. J Am Geriatr Soc. 2008;56(5):862\u201370.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"630_CR31","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1111\/jgs.13807","volume":"63","author":"JT Hanlon","year":"2015","unstructured":"Hanlon JT, Semla TP, Schmader KE. Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc. 2015;63(12):e8\u201318.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"630_CR32","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1111\/jgs.14554","volume":"64","author":"AR Green","year":"2016","unstructured":"Green AR, Oh E, Hilson L, Tian J, Boyd CM. Anticholinergic burden in older adults with mild cognitive impairment. J Am Geriatr Soc. 2016;64(12):e313\u20134.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"630_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.amjopharm.2011.10.001","volume":"9","author":"R Bhattacharya","year":"2011","unstructured":"Bhattacharya R, Chatterjee S, Carnahan RM, Aparasu RR. Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia. Am J Geriatr Pharmacother. 2011;9(6):434\u201341.","journal-title":"Am J Geriatr Pharmacother."},{"issue":"12","key":"630_CR34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2165\/11584430-000000000-00000","volume":"27","author":"S Chatterjee","year":"2010","unstructured":"Chatterjee S, Mehta S, Sherer JT, Aparasu RR. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey. Drugs Aging. 2010;27(12):987\u201397.","journal-title":"Drugs Aging"},{"issue":"3","key":"630_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40266-018-0522-x","volume":"35","author":"AR Green","year":"2018","unstructured":"Green AR, Reifler LM, Boyd CM, Weffald LA, Bayliss EA. Medication profiles of patients with cognitive impairment and high anticholinergic burden. Drugs Aging. 2018;35(3):223\u201332.","journal-title":"Drugs Aging"},{"issue":"2","key":"630_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5694\/mja14.00336","volume":"202","author":"L Parkinson","year":"2015","unstructured":"Parkinson L, Magin PJ, Thomson A, Byles JE, Caughey GE, Etherton-Beer C, et al. Anticholinergic burden in older women: not seeing the wood for the trees? Med J Aust. 2015;202(2):91\u20134.","journal-title":"Med J Aust"},{"issue":"6","key":"630_CR37","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/jama.294.6.716","volume":"294","author":"CM Boyd","year":"2005","unstructured":"Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716\u201324.","journal-title":"JAMA"},{"issue":"3","key":"630_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3122\/jabfm.2010.03.090178","volume":"23","author":"JW Mold","year":"2010","unstructured":"Mold JW, Hamm RM, McCarthy LH. The law of diminishing returns in clinical medicine: how much risk reduction is enough? J Am Board Fam Med. 2010;23(3):371\u20135.","journal-title":"J Am Board Fam Med."},{"issue":"5","key":"630_CR39","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/MEG.0b013e3282f47982","volume":"20","author":"A Sonnenberg","year":"2008","unstructured":"Sonnenberg A. Diminishing returns in sequential interventions of gastroenterology. Eur J Gastroenterol Hepatol. 2008;20(5):465\u20138.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-018-00630-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-00630-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-00630-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T22:25:52Z","timestamp":1589667952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-018-00630-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1007\/s40266-018-00630-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"17 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ariel Green, Liza Reifler, Elizabeth Bayliss, Linda A. Weffald have no conflicts of interest that are directly relevant to the content of this study. Cynthia Boyd writes a chapter on multimorbidity for <i>UpToDate<\/i>, for which she receives a royalty.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}